Optomed Plc logo

Optomed Plc (OPTOMED)

Market Closed
27 May, 10:49
XHEL XHEL
1. 5460
-0.024
-1.53%
72.01M Market Cap
- P/E Ratio
- Div Yield
26,673 Volume
- Eps
1.57
Previous Close
Add Transaction
Day Range
1.5 1.562
Year Range
1.332 4.745
Want to track OPTOMED and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

OPTOMED closed Wednesday lower at €1.55, a decrease of -1.53% from Tuesday's close, completing a monthly decrease of -32.78% or -€0.75. Over the past 12 months, OPTOMED stock lost -59.1%.
OPTOMED is not paying dividends to its shareholders.
The last earnings report, released on Yesterday at 12:00 AM, exceeded the consensus estimates by 0.07%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XDUS (EUR).

OPTOMED Chart

People also search for

United Bankers Oyj
20.4
+0.99%
Aiforia Technologies Oyj
1.85
+0.54%

Optomed Plc (OPTOMED) FAQ

What is the stock price today?

The current price is €1.5460.

On which exchange is it traded?

Optomed Plc is listed on XHEL.

What is its stock symbol?

The ticker symbol is OPTOMED.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 72.01M.

Has Optomed Plc ever had a stock split?

No, there has never been a stock split.

Optomed Plc Profile

Insurance Industry
Financials Sector
- CEO
XHEL Exchange
FI4000410881 ISIN
Finland Country
112 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Optomed Oyj stands as a pioneering entity in the medical technology domain, focusing its creative and engineering efforts on the development of portable imaging devices and advanced software solutions. These innovations are designed with the primary goal of advancing the detection and management of eye diseases, particularly underlining the importance of early detection in conditions such as diabetic retinopathy. The rising global incidence of diabetes marks this focus as especially critical. The company carves a niche for itself by offering tools that significantly bolster telemedicine and primary healthcare capabilities, areas often challenged by the accessibility to traditional, voluminous imaging machinery. Optomed Oyj ensures healthcare practitioners, regardless of their operational setting, are armed with the means to execute effective screenings, thereby elevating the standard of patient care through prompt and accurate diagnosis. Based in Finland, Optomed Oyj’s ethos is deeply rooted in innovation and its strategic role in the digitization of healthcare, aiming to address the escalating global demand for accessible and efficient eye care services.

Products and Services

  • Portable Imaging Devices

    Optomed Oyj has developed a portfolio of portable imaging devices that are revolutionizing the way eye screenings are conducted. These devices are engineered for ease of use, portability, and versatility, making them an invaluable tool in settings with limited access to traditional ophthalmic imaging equipment. By facilitating the capture of high-quality images of the eye, these devices enable early detection and management of eye diseases in a wide range of environments, from remote areas to bustling urban clinics.

  • Software Solutions

    The company complements its hardware offerings with sophisticated software solutions designed to enhance the utility of the captured images. These software tools are equipped with advanced algorithms that aid in the analysis and interpretation of ophthalmic images, supporting healthcare professionals in making accurate diagnoses. The integration of these software solutions with portable imaging devices exemplifies Optomed Oyj’s commitment to providing comprehensive eye care technology. Specifically tailored for telemedicine applications, these solutions streamline the process of remote diagnosis and patient management, thereby broadening the scope of accessible eye care services.

Contact Information

Address: Yrttipellontie 1
Phone: 358 2071 13380